Cardiovascular clinical trials

Most active in this area

• UNIWERSYTET MEDYCZNY IM PIASTOW SLASKICH WE WROCLAWIU

  Polish medical university combining cardiovascular clinical trial expertise with growing medical data science and AI capabilities for heart disease research.

  “SECURE tested polypill strategies for secondary prevention, BETA3_LVH ran a multi-center trial on mirabegron for cardiac hypertrophy, and HEARTBIT_4.0 applied data science to heart diseases.”

  PrimaryPL7 projects
• CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES

  French university hospital specializing in immunotherapy clinical trials, regulatory T cell therapies, transplant immunology, and host-targeted infection treatment.

  “BETA3_LVH is a multi-center placebo-controlled trial of mirabegron for cardiac hypertrophy and diastolic dysfunction.”

  FR7 projects
• UNIVERSITATKLINIKUM LEIPZIG

  German university hospital contributing as a clinical site to H2020 cardiovascular trials on heart failure pharmacology and aortic aneurysm surgery.

  “BETA3_LVH ran a multi-center placebo-controlled trial of the beta3-adrenergic agent mirabegron for cardiac hypertrophy, and PAPA-ARTIS is a randomized trial on paraplegia prevention in aortic aneurysm repair.”

  PrimaryDE3 projects
• GORNOSLASKIE CENTRUM MEDYCZNE IM. PROF. LESZKA GIECA SLASKIEGO UNIWERSYTETU MEDYCZNEGO W KATOWICACH

  Polish university hospital contributing cardiovascular clinical trial sites for regenerative therapies and cardiac stereotactic radiotherapy across European consortia.

  “All three H2020 projects (SCIENCE, ReGenHeart, STOPSTORM) involve clinical testing of therapies for serious cardiac conditions.”

  PrimaryPL3 projects
• PAPWORTH HOSPITAL NHS FOUNDATION TRUST

  UK's leading specialist cardiothoracic hospital contributing clinical trial sites and cardiovascular expertise to European research consortia.

  “RITA-MI and RITA-MI 2 both investigate rituximab as immunotherapy for acute myocardial infarction, spanning 2016–2026.”

  PrimaryUK3 projects